Literature DB >> 6639172

Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients.

U Veronesi, N Cascinelli, R Bufalino, A Morabito, M Greco, D Galluzzo, V Delle Donne, R De Lellis, P Piotti, V Sacchini.   

Abstract

The risk of internal mammary chain metastases according to some parameters and its prognostic relevance was evaluated on the basis of the experience collected at the National Cancer Institute of Milan where, from January 1965 to December 1980, 1085 patients were submitted to Halsted mastectomy plus internal mammary chain dissection. A multivariate analysis was carried out, resorting to a multiple linear regression with logistic transformation of the dependent variable. The selection of prognostic factors has been performed with a step-down approach. The frequency of metastases to internal mammary chain nodes was evaluated according to four criteria: age, site and size of primary tumor, and presence of axillary metastases. Data of this series indicate that the frequency of internal mammary node metastases is significantly associated with the age of the patients (younger patients have a higher risk) (p = 0.006) with the size of primary tumor (p = 0.006) with the presence of axillary node metastases (p = 10(-9). Patients with both axillary and internal mammary positive nodes have a very poor prognosis (10-year survival 37.3%) while patients with either axillary metastases only or internal mammary metastases only have an intermediate less grave prognosis (59.6% and 62.4%, respectively). As regards the risk of internal mammary nodes involvement, it appears that knowing the age, the size, and the axillary nodes status, it is possible to calculate with good approximation the probability of their invasion.

Entities:  

Mesh:

Year:  1983        PMID: 6639172      PMCID: PMC1353213          DOI: 10.1097/00000658-198312000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

1.  Invasion of internal mammary lymph nodes in carcinoma of the breast.

Authors:  R S HANDLEY; A C THACKRAY
Journal:  Br Med J       Date:  1954-01-09

2.  Surgical treatment of primary breast cancer.

Authors:  U Veronesi; A Costa; C Grandi
Journal:  Schweiz Med Wochenschr       Date:  1977-07-16

3.  Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial.

Authors:  B Fisher; E Montague; C Redmond; B Barton; D Borland; E R Fisher; M Deutsch; G Schwarz; R Margolese; W Donegan; H Volk; C Konvolinka; B Gardner; I Cohn; G Lesnick; A B Cruz; W Lawrence; T Nealon; H Butcher; R Lawton
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

Review 4.  Management of operable breast cancer: the surgeon's view.

Authors:  J A Urban
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

5.  Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study.

Authors:  J Lacour; P Bucalossi; E Cacers; G Jacobelli; T Koszarowski; M Le; C Rumeau-Rouquette; U Veronesi
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

6.  Inefficacy of internal mammary nodes dissection in breast cancer surgery.

Authors:  U Veronesi; P Valagussa
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

  6 in total
  39 in total

1.  [Sentinel lymph node biopsy in breast cancer].

Authors:  A Rody; C Solbach; M Kaufmann
Journal:  Chirurg       Date:  2004-08       Impact factor: 0.955

Review 2.  Radiation therapy after breast-conserving surgery.

Authors:  Naoyuki Shigematsu; Atsuya Takeda; Naoko Sanuki; Junichi Fukada; Takashi Uno; Hisao Ito; Osamu Kawaguchi; Etsuo Kunieda; Atsushi Kubo
Journal:  Radiat Med       Date:  2006-06

3.  Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation?

Authors:  Jean-Cyril Bourre; Raoul Payan; Delphine Collomb; Céline Gallazzini-Crepin; Alex Calizzano; Marie-Dominique Desruet; Dominique Pasquier; Michel Bolla; Daniel Fagret; Jean-Philippe Vuillez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-14       Impact factor: 9.236

4.  Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients.

Authors:  Pilar Paredes; Sergi Vidal-Sicart; Gabriel Zanón; Jaume Pahisa; Pedro Luís Fernández; Martín Velasco; Gorane Santamaría; Jaime Ortín; Joan Duch; Francesca Pons
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07-09       Impact factor: 9.236

5.  Ultrasono-anatomy for evaluation of the local lymphatic groups of the mamma.

Authors:  B Moriggl; M Steinlechner
Journal:  Surg Radiol Anat       Date:  1994       Impact factor: 1.246

6.  Nipple-areola-complex sparing mastectomy: five years of experience in a single centre.

Authors:  Antonio Tancredi; Luigi Ciuffreda; Lucia Petito; Francesca Natale; Roberto Murgo
Journal:  Updates Surg       Date:  2013-07-26

7.  Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control.

Authors:  Yu-Jing Zhang; Julia L Oh; Gary J Whitman; Puneeth Iyengar; Tse-Kuan Yu; Welela Tereffe; Wendy A Woodward; George Perkins; Thomas A Buchholz; Eric A Strom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-12-11       Impact factor: 7.038

Review 8.  Sentinel lymph node biopsy progress in surgical treatment of cancer.

Authors:  T Schulze; A Bembenek; P M Schlag
Journal:  Langenbecks Arch Surg       Date:  2004-06-09       Impact factor: 3.445

9.  Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases.

Authors:  Wolfgang Janni; Brigitte Rack; Harald Sommer; Maren Schmidt; Barbara Strobl; Dorothea Rjosk; Elisabeth Klanner; Wiebke Thieleke; Bernd Gerber; Klaus Friese; Thomas Dimpfl
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-18       Impact factor: 4.553

Review 10.  Breast cancer (non-metastatic).

Authors:  Justin Stebbing; Geoff Delaney; Alistair Thompson
Journal:  BMJ Clin Evid       Date:  2007-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.